Navigation Links
Solta Medical Announces New Fraxel re:store(R) Dual Laser System, Receives CE Mark for European Market
Date:11/18/2009

HAYWARD, Calif., Nov. 18 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and market leader of aesthetic skin treatments, today announced its European launch of the Fraxel re:store Dual laser system with the recent CE Mark (Conformite Europeene) approval. The Fraxel re:store Dual system takes the industry leading fractional laser technology to the next level by adding a novel 1927 nm wavelength, the first ever application of a Thulium laser in the aesthetics market. The new Fraxel re:store Dual system is optimized for both facial procedures and large body areas to address clearance of pigmentation and other skin conditions all in a single treatment. The system is now available to physicians in the European Union, as well as many other countries around the world. This CE Mark joins the registration obtained in September for Solta Medical's Thermage CPT, the most advanced non-invasive skin tightening and contouring procedure.

Prior to the non-ablative Fraxel re:store Dual system, laser skin resurfacing procedures were largely limited to the face. The expanded versatility of the Fraxel re:store Dual system, with the addition of the new 1927 nm wavelength, increases the areas of the body that physicians can treat and further demonstrates Solta Medical's dedication to producing the safest and most effective aesthetic energy devices in the industry.

"Solta Medical is committed to developing innovative, safe, and effective anti-aging solutions that deliver superior results for patients looking to treat multiple body areas in one treatment session," said Stephen J. Fanning, Chairman of the Board, President and CEO of Solta Medical, Inc. "With the recent domestic and global registrations for our Fraxel re:store Dual and Thermage CPT systems, we have made significant advancements in how physicians address aging skin - with enhanced efficacy and patient comfort in non-invasive aesthetic treatments.

The new Fraxel re:store Dual system provides significant enhancements that enable physicians to better address pigmentation and other dyschromia on the entire body. Fraxel re:store Dual system features and benefits include:

  • Dual fiber laser technology in one system providing the most effective non-ablative skin resurfacing treatment
  • Accelerated clearance of unwanted pigmentation via ground-breaking technology
  • Ease of operation and improved patient comfort with focal cooling built directly into the hand piece
  • Treatment of larger and multiple body areas in a single session with the addition of the 1927 nm wavelength
  • Increased procedure speed by 25% with newly improved scanner design

ABOUT SOLTA MEDICAL, INC.

Solta Medical is a global leader in the medical aesthetics market providing innovative, safe, and effective anti-aging solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address aging skin under the industry's two premier brands: Thermage® and Fraxel®. Thermage is an innovative, non- invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Since 2002, approximately one million Thermage and Fraxel procedures have been performed in nearly 80 countries. Thermage and Fraxel are the perfect complement for any aesthetic practice. For more information about Solta Medical, call 1-877-782-2286 or log on to http://www.Solta.com.

The Fraxel re:store 1550 nm laser is FDA cleared for skin resurfacing and for the treatment of pigmented lesions, acne scars, melasma, mild to moderate periorbital rhytids, surgical scars and actinic keratosis. The Fraxel re:store 1927 nm laser is FDA cleared for dermatological procedures requiring the coagulation of soft tissue.

© 2009 Solta Medical, Inc. All rights reserved. Thermage, Fraxel, Fraxel re:store and Solta Medical are trademarks or registered trademarks of Solta Medical, Inc. or its subsidiaries.

SOURCE Solta Medical, Inc.


'/>"/>
SOURCE Solta Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Solta Medical Announces FDA 510(k) Clearance of New Fraxel re:store(R) Dual Laser System
2. Reportlinker Adds Medical Ultrasound Equipment - A Global Market Perspective
3. Varian Medical Systems to Showcase the Latest X-Ray Image Detectors and X-Ray Tubes at the MEDICA 2009 International Trade Fair
4. Benevolence Beyond Politics, Inc. Announces Position to Provide Financial and Logistical Support for Humanitarian and Medical Missions Worldwide
5. OCTANes Medical Device & Investor Forum Highlights Key Trends, Investment Opportunities
6. China Sky One Medical, Inc. Announces Record Third Quarter 2009 Results
7. Symmetry Medical to Present at 21st Annual Piper Jaffray Health Care Conference
8. Cardo Medical, Inc. Announces Closing of $6.2 Million Private Placement
9. Methodist Dallas Medical Center First in Metroplex to Perform Kidney Transplant on HIV Positive Patient
10. New Database from ANSI, AAMI, ASTM International, and DIN Provides Centralized Source of Information for Medical Device Professionals
11. CardioGenics Holdings Inc. Featured in Medical Device Daily
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... May 4, 2016 Yissum ... announced today that it had signed an exclusive ... , developer of novel protein degradation and immunomodulatory drugs ... commercialization of drug candidates representing first-in-class therapy for hematologic ... not disclosed. The novel technology was developed ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Multiple Myeloma Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Competitive Landscape Highlights 2016, provides comprehensive insights ... epidemiology, Multiple Myeloma market valuations and forecast, ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Actinic Keratosis Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Actinic Keratosis epidemiology, Actinic Keratosis market valuations ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... May 04, 2016 , ... Qualitative ... seeks to add a deeper understanding of the program, policy or intervention being ... answers different yet important questions. , In a new brief released today, Reading ...
(Date:5/4/2016)... SCOTTSDALE, AZ (PRWEB) , ... May 04, 2016 ... ... 2016 Annual Technology & Business Conference. The conference opened on Tuesday with Frank ... panel discussion on NCPDP’s PDMP Solution provided a deep dive on NCPDP’s model ...
(Date:5/4/2016)... ... May 04, 2016 , ... The RIDER Institute announces ... of DRACO broad-spectrum antiviral therapeutics. DRACOs have proven effective against all 18 viruses ... 2016 at http://igg.me/at/EndTheVirus and runs for 60 days, we are raising ...
(Date:5/4/2016)... ... May 04, 2016 , ... a2z, Inc. is ... and Canadian Association for Enterostomal Therapy (CAET) will be utilizing powerful and innovative ... to attendees and exhibitors for the 2016 WOCN Society & CAET Joint Conference—which ...
(Date:5/4/2016)... ... ... May kicked off with Melanoma Monday , a multi-agency effort to raise ... encouraging her patients, as well as residents all around Dallas, Cleburne, Irving, and Plano, ... in the future. , The dermatology-specific awareness month ends with “Don’t Fry Day,” established ...
Breaking Medicine News(10 mins):